A multi-centre UK-based survey on angioedema secondary to acquired C1 inhibitor deficiency.
Morsi H, Huissoon A, Grammatikos A, Whyte AF, Manson A, Ekbote A, Sivadasan A, Boulton APR, Herwadkar A, Anantharachagan A, Price A, Steele C, Stroud C, Chopra C, Arnold D, Eren E, Cleave E, Drewe E, Moon E, Zinser E, Hayman G, Alachkar H, Ghanta H, Bourne H, Abdelhakam I, Dempster J, Townsend K, Sooriyakumar K, Lorenzo L, Dziadzio M, Ahuja M, Prasinou M, Frleta-Gilchrist M, Zhang M, Thomas M, Vijayadurai P, Vaitla PM, Sargur R, Herriot R, Yellon RL, Murng SHK, Drinkwater S, Denness S, Denman S, Elkhalifa S, Savic S, Kiani-Alikhan S, Coulter TI, El-Shanawany T, Rahman T, Garcez T, Yong PFK, Jain R.
Morsi H, et al. Among authors: sivadasan a.
Clin Exp Immunol. 2025 Jan 21;219(1):uxae121. doi: 10.1093/cei/uxae121.
Clin Exp Immunol. 2025.
PMID: 39756409